A woman wearing a mask walks by graffiti art on a roadside wall in Bangalore India on May 15. India’s entire US$7 billion vaccine budget would buy enough Pfizer doses for less than a sixth of its population. Photo: EPA-EFE A woman wearing a mask walks by graffiti art on a roadside wall in Bangalore India on May 15. India’s entire US$7 billion vaccine budget would buy enough Pfizer doses for less than a sixth of its population. Photo: EPA-EFE
A woman wearing a mask walks by graffiti art on a roadside wall in Bangalore India on May 15. India’s entire US$7 billion vaccine budget would buy enough Pfizer doses for less than a sixth of its population. Photo: EPA-EFE

Letters | Coronavirus vaccines offer hope, but can developing countries surmount cost and logistical hurdles?

  • Pfizer’s vaccine, for example, requires ultra-cold storage facilities that many developing countries may not have. Moreover, the cost of the vaccine is also an impediment.

Topic |   Coronavirus pandemic: All stories
A woman wearing a mask walks by graffiti art on a roadside wall in Bangalore India on May 15. India’s entire US$7 billion vaccine budget would buy enough Pfizer doses for less than a sixth of its population. Photo: EPA-EFE A woman wearing a mask walks by graffiti art on a roadside wall in Bangalore India on May 15. India’s entire US$7 billion vaccine budget would buy enough Pfizer doses for less than a sixth of its population. Photo: EPA-EFE
A woman wearing a mask walks by graffiti art on a roadside wall in Bangalore India on May 15. India’s entire US$7 billion vaccine budget would buy enough Pfizer doses for less than a sixth of its population. Photo: EPA-EFE
READ FULL ARTICLE